학술논문
Safety and immunogenicity of an Ad26.ZEBOV booster dose in children previously vaccinated with the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen: an open-label, non-randomised, phase 2 trial
Document Type
Article
Author
Manno, Daniela ; Bangura, Agnes; Baiden, Frank; Kamara, Abu Bakarr; Ayieko, Philip; Kallon, Joseph; Foster, Julie; Conteh, Musa; Connor, Nicholas Edward; Koroma, Bockarie; Njie, Yusupha; Borboh, Paul; Keshinro, Babajide; Lawal, Bolarinde Joseph; Kroma, Mattu Tehtor; Otieno, Godfrey Tuda; Deen, Abdul Tejan; Choi, Edward Man-Lik; Balami, Ahmed Dahiru; Gaddah, Auguste; McLean, Chelsea; Luhn, Kerstin; Adetola, Hammed Hassan; Deen, Gibrilla Fadlu; Samai, Mohamed; Lowe, Brett; Robinson, Cynthia; Leigh, Bailah; Greenwood, Brian; Watson-Jones, Deborah
Source
In The Lancet Infectious Diseases March 2023 23(3):352-360
Subject
Language
ISSN
1473-3099